Advertisement
Advertisement
U.S. markets open in 3 hours 18 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Dermata Therapeutics, Inc. (DRMA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.6449+0.0075 (+1.18%)
At close: 03:40PM EST
0.6500 +0.01 (+0.79%)
After hours: 07:52PM EST
Advertisement
Full screen
Loading interactive chart...
  • ACCESSWIRE

    Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results

    Dermata Therapeutics, Inc. (Nasdaq:DRMA;DRMAW) ("Dermata," or the "Company"), a clinical-stage biopharmaceutical company focusing on the treatment of medical and aesthetic skin conditions, today highlighted recent corporate progress, and reported financial results for the quarter ended September 30, 2022.

  • ACCESSWIRE

    Dermata to Present at the H.C. Wainwright 24th Annual Global Investment Conference

    Dermata Therapeutics, Inc. (Nasdaq:DRMA) ("Dermata" or the "Company"), a clinical-stage biotechnology company focusing on the treatment of medical and aesthetic skin conditions, today announced that Gerry Proehl, Dermata's Chairman of the Board, President, and Chief Executive Officer will present a company overview at the H.C. Wainwright 24th Annual Global Investment Conference being held September 12-14, 2022.

  • ACCESSWIRE

    Dermata to Participate in the Gilmartin Group Emerging Growth Company Showcase

    / Dermata Therapeutics, Inc. (Nasdaq:DRMA) ("Dermata," or the "Company"), a clinical-stage biotechnology company focusing on the treatment of medical and aesthetic skin conditions, today announced that Dermata will participate in the Gilmartin Group Emerging Growth Company Showcase, being held on August 31, 2022.

Advertisement
Advertisement